IL17A and myeloid sarcoma: A meta-analysis evaluating Th17 cell status and Th17 related cytokines in the peripheral blood of MS patients revealed that the proportion of Th17 cells, and the levels of IL-17 and IL-23 were increased compared to control subjects (34), strongly suggesting that Th17-related responses contributes to MS pathogenesis.